- 专利标题: TUMOR IMAGING WITH X-RAYS AND OTHER HIGH ENERGY SOURCES USING AS CONTRAST AGENTS PHOTON-EMITTING PHOSPHORS HAVING THERAPEUTIC PROPERTIES
-
申请号: US18360187申请日: 2023-07-27
-
公开(公告)号: US20240042233A1公开(公告)日: 2024-02-08
- 发明人: Harold WALDER , Frederic A. BOURKE, JR. , Zakaryae FATHI , Wayne F. BEYER, JR. , Mark DEWHIRST , Mark OLDHAM , Justus ADAMSON , Michael NOLAN
- 申请人: Immunolight, LLC , DUKE UNIVERSITY
- 申请人地址: US MI Detroit
- 专利权人: Immunolight, LLC,DUKE UNIVERSITY
- 当前专利权人: Immunolight, LLC,DUKE UNIVERSITY
- 当前专利权人地址: US MI Detroit; US NC Durham
- 分案原申请号: US16728803 2019.12.27
- 主分类号: A61N5/06
- IPC分类号: A61N5/06 ; A61K41/17 ; A61K39/00 ; A61K41/00 ; A61K49/04 ; A61N5/02 ; A61N5/10
摘要:
A system and method for imaging or treating a disease in a human or animal body. The system provides to the human or animal body a pharmaceutical carrier including one or more phosphors which are capable of emitting ultraviolet or visible light into the body and which provide x-ray contrast. The system includes one or more devices which infuse a diseased site with a photoactivatable drug and the pharmaceutical carrier, an initiation energy source comprising an x-ray or high energy source which irradiates the diseased site with at least one of x-rays, gamma rays, or electrons to thereby initiate emission of said ultraviolet or visible light into the body, and a processor programmed to at least one of 1) produce images of the diseased site or 2) control a dose of said x-rays, gamma rays, or electrons to the diseased site for production of said ultraviolet or visible light at the diseased site to activate the photoactivatable drug.
信息查询